Tirzepatide Peptide For sale.
In the rapidly evolving field of metabolic science, Tirzepatide peptide has emerged as a cornerstone for modern laboratory investigation. As a synthetic dual agonist, Tirzepatide is engineered to target both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. At Polaris Peptides, we provide high-purity research materials to help scientists decode the synergistic mechanisms of these “twincretin” pathways, particularly their impact on systemic metabolic regulation and adipose tissue signaling.
The Biochemistry of Dual Agonism
The Tirzepatide peptide is a 39-amino-acid chain that represents a significant departure from traditional single-agonist models. By mimicking the action of native GIP while selectively activating the GLP-1 receptor, Tirzepatide allows researchers to study complex metabolic interactions that were previously difficult to isolate.
In controlled research environments, this dual-receptor activity is frequently analyzed for its role in enhancing insulin sensitivity and modulating central nervous system signals related to satiety. For labs focused on metabolic dysfunction, Tirzepatide offers a robust platform for observing nutrient-stimulated hormone responses in vivo.
Precision Concentrations for Diverse Study DesignsPolaris Peptides offers a range of specific concentrations to support various phases of longitudinal research, from initial pilot studies to high-volume chronic experimentation.Micro-Dosing and Titration: Tirzepatide 5mg & 10mgFor early-stage research or establishing a baseline dose-response curve, our lower-concentration vials provide the necessary precision.Tirzepatide 5mg: Primarily utilized for acute exposure studies or short-duration toxicity screens where minimal volume is required.Tirzepatide 10mg: A standard for dose-ranging experiments, allowing researchers to observe the transition from low-level receptor binding to full agonist saturation in animal models.Extended and High-Throughput Research: Tirzepatide 30mg & 50mgWhen studies involve large cohorts or require long-term maintenance of a steady-state hormonal profile, our higher-capacity vials ensure batch consistency and experimental reliability.Tirzepatide 30mg: Designed for intermediate-length studies, providing a sufficient reservoir for multiple subjects while maintaining the chemical stability of the lyophilized powder.Tirzepatide 50mg: Our most robust concentration, the Tirzepatide 50mg vial, is the preferred choice for high-throughput laboratories. It minimizes the variables associated with frequent reconstitution and batch changes, ensuring data integrity across extensive study timelines.Polaris Peptides Quality AssuranceWe understand that the validity of your research depends on the purity of your peptides. Every batch of Tirzepatide peptide supplied by Polaris Peptides undergoes rigorous analytical testing to ensure the highest standards:Purity Levels: $\geq 99\%$ purity as verified by High-Performance Liquid Chromatography (HPLC).Stability: Provided in a lyophilized (freeze-dried) state to maximize shelf-life. Store at $-20$°C for optimal long-term preservation.Molecular Verification: Confirmed via Mass Spectrometry to ensure a consistent molecular mass of approximately 4813.45 Da.Strictly for Research and Laboratory UseAll products, including Tirzepatide 5mg, 10mg, 30mg, and 50mg, are intended STRICTLY for research and laboratory use only. Polaris Peptides does not supply materials for human consumption, medical diagnosis, or therapeutic application. By purchasing, you represent that you are a qualified professional working in a controlled laboratory setting.Technical Support & DocumentationIf your project requires a specific Certificate of Analysis (COA) or technical data sheet for your audit trail, please contact our team at sales@polaris-peptide.com.Polaris Peptides 302 S Jones Blvd, Suite 3020Las Vegas, NV 89107